Sylvie Freeman

Assessment of Minimal Residual Disease in Standard-Risk AML

Adam Ivey, Robert K. Hills, Michael A. Simpson et al. · New England Journal of Medicine · 2016 · 812 citations · Full text

2021 Update on MRD in acute myeloid leukemia: a consensus document from the European LeukemiaNet MRD Working Party

Michael Heuser, Sylvie Freeman, Gert J. Ossenkoppele et al. · Blood · 2021 · 666 citations · Full text

Mixed-phenotype Acute Leukemia, Pathology, Measurable Residual Disease +16

Addition of Gemtuzumab Ozogamicin to Induction Chemotherapy Improves Survival in Older Patients With Acute Myeloid Leukemia

Alan K. Burnett, Nigel H. Russell, Robert K. Hills et al. · Journal of Clinical Oncology · 2012 · 402 citations · Full text

Prognostic Relevance of Treatment Response Measured by Flow Cytometric Residual Disease Detection in Older Patients With Acute Myeloid Leukemia

Sylvie Freeman, Paul Virgo, Steve Couzens et al. · Journal of Clinical Oncology · 2013 · 311 citations

MHC Class I–Associated Phosphopeptides Are the Targets of Memory-like Immunity in Leukemia

Mark Cobbold, Hugo De La Peña, Andrew J. Norris et al. · Science Translational Medicine · 2013 · 202 citations